Boundless Bio BOLD
NASDAQ BOLD
$2.45 -0.01 (-0.41%)
At close: Nov 10, 2026 · 4:00 PM EST

Boundless Bio (BOLD) Net Equity Issued and Repurchased (2023 - 2026)

Updated

Boundless Bio's Net Equity Issued and Repurchased came in at $24,000 for Q4 2025.

Analysis

Boundless Bio (BOLD) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends

For FY2025, Boundless Bio's Net Equity Issued and Repurchased was $141,000, down 99.8% from FY2024.

  • Going back by year, Net Equity Issued and Repurchased was $93 million in FY2024 (-6.7%) and $99.67 million in FY2023.
  • The Q4 2025 figure represents the highest quarterly Net Equity Issued and Repurchased since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Boundless Bio 56.02 Mn -189.91 Mn - 776,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 776,000.00
Dec 31, 2025 24,000.00
Dec 31, 2024 113,000.00
Jun 30, 2024 93.00 Mn
Mar 31, 2024 59,000.00
Dec 31, 2023 -290,000.00
Sep 30, 2023 86,000.00
Jun 30, 2023 26,000.00
Mar 31, 2023 31,000.00
API Access

Boundless Bio Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BOLD&period=max&api_key=YOUR_API_KEY